AEON Biopharma, Inc. (AEON) is a publicly traded Healthcare sector company. As of May 21, 2026, AEON trades at $0.86 with a market cap of $22.49M and a P/E ratio of -0.22. AEON moved +0.91% today. Year to date, AEON is -23.64%; over the trailing twelve months it is +69.63%. Its 52-week range spans $0.38 to $115.57. Rallies surfaces AEON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded AEON stock?
Rallies tracks politician and congressional stock disclosures for AEON, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
FISCHER JOST bought 60.00K (~$29.25K) on May 21, 2025.
FISCHER JOST bought 60.00K (~$30.36K) on May 20, 2025.
FISCHER JOST bought 50.00K (~$24.94K) on May 19, 2025.
AEON Analyst Consensus
AEON analyst coverage data. Average price target: $0.00.
Common questions about AEON
Which politicians traded AEON stock?
Rallies tracks politician and congressional stock disclosures for AEON, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in AEON?
Yes. Rallies tracks politician and congressional stock disclosures for AEON, including reported purchases, sales, dates, owners, and trade amounts when available.
Is AEON research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AEON. It does not provide personalized investment advice.
